{
    "title": "Provention prices diabetes drug above analysts' estimates at $13,850/vial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11444069/Provention-Bio-diabetes-drug-cost-13-850-vial.html",
    "date": "2022-11-18",
    "keywords": [
        "drug",
        "course",
        "type",
        "price",
        "raghav",
        "mahobe",
        "srinivasan",
        "provention",
        "pricing",
        "insurance",
        "company",
        "analyst",
        "bio",
        "inc",
        "teplizumab",
        "vial",
        "friday",
        "day",
        "approval",
        "companys",
        "premarket",
        "coverage",
        "food",
        "administration",
        "thursday",
        "use",
        "onset",
        "insulin",
        "dependence",
        "regimen",
        "conference",
        "call",
        "street",
        "gregory",
        "renza",
        "capital",
        "level",
        "concern",
        "david",
        "hoang",
        "treatment",
        "diabetes",
        "disease",
        "destruction",
        "beta",
        "copromotion",
        "deal",
        "drugmaker",
        "negotiation",
        "exchange",
        "payment",
        "class",
        "anticd3",
        "blood",
        "bodys",
        "response",
        "reporting",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi",
        "shinjini",
        "ganguli",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}